GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OWC Pharmaceutical Research Corp (OTCPK:OWCP) » Definitions » Book Value per Share

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Book Value per Share : $-0.02 (As of Sep. 2019)


View and export this data going back to 2008. Start your Free Trial

What is OWC Pharmaceutical Research Book Value per Share?

OWC Pharmaceutical Research's book value per share for the quarter that ended in Sep. 2019 was $-0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

OWC Pharmaceutical Research's current price is $0.0001. Its book value per share for the quarter that ended in Sep. 2019 was $-0.02. Hence, today's PB Ratio of OWC Pharmaceutical Research is .


OWC Pharmaceutical Research Book Value per Share Historical Data

The historical data trend for OWC Pharmaceutical Research's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OWC Pharmaceutical Research Book Value per Share Chart

OWC Pharmaceutical Research Annual Data
Trend Dec08 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Book Value per Share
Get a 7-Day Free Trial Premium Member Only 0.02 - - 0.01 -0.06

OWC Pharmaceutical Research Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.06 -0.06 -0.01 -0.02

Competitive Comparison of OWC Pharmaceutical Research's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, OWC Pharmaceutical Research's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OWC Pharmaceutical Research's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OWC Pharmaceutical Research's PB Ratio distribution charts can be found below:

* The bar in red indicates where OWC Pharmaceutical Research's PB Ratio falls into.



OWC Pharmaceutical Research Book Value per Share Calculation

OWC Pharmaceutical Research's Book Value Per Share for the fiscal year that ended in Dec. 2018 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-9.44-0.00)/150.21
=-0.06

OWC Pharmaceutical Research's Book Value Per Share for the quarter that ended in Sep. 2019 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-4.01-0.00)/244.48
=-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


OWC Pharmaceutical Research  (OTCPK:OWCP) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


OWC Pharmaceutical Research Book Value per Share Related Terms

Thank you for viewing the detailed overview of OWC Pharmaceutical Research's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


OWC Pharmaceutical Research (OWC Pharmaceutical Research) Business Description

Traded in Other Exchanges
N/A
Address
2 Ben Gurion Street, Ramat Gan, ISR, 5257334
OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.
Executives
Asher Zwebner director, officer: CHIEF FINANCIAL OFFICER CDOOR CORPORATION, 20 A REHOV SHAREI TORAH BAYIT VEGAN, JERUSALEM L3 96387

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Headlines

From GuruFocus

OWC Pharmaceutical Research Corp Announced Personnel Changes

By PRNewswire PRNewswire 08-21-2018

OWC Pharmaceutical Research Corp, Letter to Shareholders

By PRNewswire PRNewswire 02-11-2019